BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15890715)

  • 1. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea.
    Lee S; Park YJ; Kim M; Lee HK; Han K; Kang CS; Kang MW
    J Antimicrob Chemother; 2005 Jul; 56(1):122-7. PubMed ID: 15890715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
    Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
    Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ; Tsai SH; Chuang CL; Wu JJ
    J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ; Hsueh PR; Lu JJ; Chang FY; Ko WC; Wu JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):530-6. PubMed ID: 16816399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of SHV-type extended spectrum beta-lactamase genes in Pseudomonas aeruginosa by PCR-restriction fragment length polymorphism and insertion site restriction-PCR].
    Kalai Blagui S; Achour W; Abdeladhim A; Ben Hassen A
    Pathol Biol (Paris); 2009 Jul; 57(5):420-4. PubMed ID: 18838231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia.
    Kalai Blagui S; Achour W; Abbassi MS; Bejaoui M; Abdeladhim A; Ben Hassen A
    Clin Microbiol Infect; 2007 Aug; 13(8):794-800. PubMed ID: 17610599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study.
    Brasme L; Nordmann P; Fidel F; Lartigue MF; Bajolet O; Poirel L; Forte D; Vernet-Garnier V; Madoux J; Reveil JC; Alba-Sauviat C; Baudinat I; Bineau P; Bouquigny-Saison C; Eloy C; Lafaurie C; Siméon D; Verquin JP; Noël F; Strady C; De Champs C
    J Antimicrob Chemother; 2007 Nov; 60(5):956-64. PubMed ID: 17804424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals.
    Celenza G; Pellegrini C; Caccamo M; Segatore B; Amicosante G; Perilli M
    J Antimicrob Chemother; 2006 May; 57(5):975-8. PubMed ID: 16510850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.
    Kim JY; Park YJ; Kwon HJ; Han K; Kang MW; Woo GJ
    J Antimicrob Chemother; 2008 Sep; 62(3):479-83. PubMed ID: 18606785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.
    Schlesinger J; Navon-Venezia S; Chmelnitsky I; Hammer-Münz O; Leavitt A; Gold HS; Schwaber MJ; Carmeli Y
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1150-6. PubMed ID: 15728917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
    Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
    J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
    Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
    J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
    Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
    J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SHV-1 beta-lactamase in Pseudomonas aeruginosa strains by genetic methods.
    Kalai Blagui S; Achour W; Bejaoui M; Abdeladhim A; Ben Hassen A
    Pathol Biol (Paris); 2009 May; 57(3):e73-5. PubMed ID: 18456431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of blaOXA-128 and blaOXA-129, two novel OXA-type extended-spectrum-β-lactamases in Pseudomonas aeruginosa, in Hunan Province, China.
    Liu W; Liu X; Liao J; Zhang Y; Liang X
    J Basic Microbiol; 2010 Dec; 50 Suppl 1():S116-9. PubMed ID: 20967789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia.
    Libisch B; Poirel L; Lepsanovic Z; Mirovic V; Balogh B; Pászti J; Hunyadi Z; Dobák A; Füzi M; Nordmann P
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):330-8. PubMed ID: 19049645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.